Oxford, J. S. (John Sidney)
Oxford, John.
John Oxford British virologist (born 1942)
Oxford, John Sidney, 1942-
Oxford, J. S
Oxford, John, 19..-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Oxford, J. S. (1942- )
Oxford, John S.
Oxford, John S. 1942-
Oxford, John S. (John Sidney), Virologie
Oxford, John Sidney
Oxford, J. S. (John Sidney), 1942-
VIAF ID: 76377030 (Personal)
Permalink: http://viaf.org/viaf/76377030
Preferred Forms
-
100 0 _
‡a
John Oxford
‡c
British virologist (born 1942)
-
200 _ | ‡a Oxford ‡b John Sidney ‡f 1942-....
-
100 1 _
‡a
Oxford, J. S
-
100 1 _ ‡a Oxford, J. S. ‡d (1942- )
-
100 1 _ ‡a Oxford, J. S. ‡q (John Sidney)
-
100 1 _
‡a
Oxford, J. S.
‡q
(John Sidney)
-
100 1 _ ‡a Oxford, J. S. ‡q (John Sidney)
-
100 1 _
‡a
Oxford, J. S.
‡q
(John Sidney)
-
100 1 _ ‡a Oxford, J. S. ‡q (John Sidney), ‡d 1942-
-
100 1 _ ‡a Oxford, John (sparse)
-
100 1 _ ‡a Oxford, John
-
100 1 _ ‡a Oxford, John S.
-
100 1 _
‡a
Oxford, John S.
‡d
1942-
-
100 1 _ ‡a Oxford, John S. ‡q (John Sidney), ‡c Virologie
-
100 1 _ ‡a Oxford, John Sidney
-
100 1 _ ‡a Oxford, John Sidney, ‡d 1942-
-
100 1 _
‡a
Oxford, John,
‡d
19..-....
-
100 1 _ ‡a Oxford, John.
4xx's: Alternate Name Forms (28)
Works
| Title | Sources |
|---|---|
| 1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants. |
|
| Aids and aids-related infections current strategies for prevention and therapy |
|
| Animal models in influenza vaccine testing. |
|
| The burden of influenza B: a structured literature review |
|
| Chemoprophylaxis and virus infections of the respiratory tract |
|
| Chemotherapy and control of influenza |
|
| Chemotherapy of herpes simplex virus infections |
|
| Clinical, scientific and ethnographic studies of influenza in quarantine |
|
| Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals |
|
| Conquest of viral diseases, 1985:CIP t.p. (John S. Oxford) |
|
| Conquest of viral diseases : a topical review of drugs and vaccines |
|
| Correlation between human leukocyte antigen class II alleles and HAI titers detected post-influenza vaccination |
|
| The current threat of avian influenza A is real and not a mirage. |
|
| The Determinants of Reported Personal and Household Hygiene Behaviour: A Multi-Country Study |
|
| DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial |
|
| Effectiveness of H1N1 vaccination in Scotland, UK. |
|
| The elephant man, c1999: |
|
| Factors influencing inappropriate antibiotic prescription in Europe |
|
| Flu: Effect of Vaccine in Elderly Care Home Residents: A Randomized Trial |
|
| Functional and antigenic analyses of the 1918 influenza virus haemagglutinin using a recombinant vaccinia virus expression system. |
|
| Human genetics and responses to influenza vaccination: clinical implications |
|
| Human microbial challenge: the ultimate animal model |
|
| Human virology |
|
| Immunogold electron microscopy recognizes prion protein-associated particles prepared from scrapie-infected mouse brain |
|
| Influenza A: a threatening virus with two faces. |
|
| Influenza Surveillance |
|
| Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge |
|
| Lack of evidence for complete resistance of peripheral blood mononuclear cells to HIV-1 and HIV-2 infection |
|
| Low pH gel intranasal sprays inactivate influenza viruses in vitro and protect ferrets against influenza infection. |
|
| Meeting report: risk assessment of tamiflu use under pandemic conditions. |
|
| Modification of pH Conferring Virucidal Activity on Dental Alginates |
|
| More action, less resistance: report of the 2014 summit of the Global Respiratory Infection Partnership |
|
| New antiviral drugs, vaccines and classic public health interventions against SARS coronavirus |
|
| New millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors. |
|
| A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community |
|
| The next pandemic |
|
| Non-responders to egg grown influenza vaccine seroconvert after booster immunization with MDCK cell grown vaccine. |
|
| Oseltamivir in the management of influenza. |
|
| Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impacts. |
|
| Pre-existing immunity in human challenge studies of influenza transmission – Authors' reply |
|
| Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine |
|
| Preclinical in vitro activity of QR-435 against influenza A virus as a virucide and in paper masks for prevention of viral transmission |
|
| Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans |
|
| Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans |
|
| Preparing for the first influenza pandemic of the 21st century. |
|
| Prescriber and Patient Responsibilities in Treatment of Acute Respiratory Tract Infections — Essential for Conservation of Antibiotics. |
|
| The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection |
|
| Problems of antiviral therapy |
|
| Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine |
|
| The survival of influenza A(H1N1)pdm09 virus on 4 household surfaces. |
|
| A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans. |
|
| The threat of avian influenza H5N1: 'do we have the tools for the job'? |
|
| A throat lozenge containing amyl meta cresol and dichlorobenzyl alcohol has a direct virucidal effect on respiratory syncytial virus, influenza A and SARS-CoV |
|
| Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing |
|
| Unanswered questions about the 1918 influenza pandemic: origin, pathology, and the virus itself |
|
| Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study. |
|
| A view from the virology research laboratory |
|
| Viral load drives disease in humans experimentally infected with respiratory syncytial virus |
|
| Virus-specific antibody secreting cell, memory B-cell, and sero-antibody responses in the human influenza challenge model. |
|
| Wirusologia : podręcznik dla studentów medycyny, stomatologii i mikrobiologii |
|
| Would you volunteer to be quarantined and infected with influenza virus? |
|
